TNYA
Tenaya Therapeutics, Inc.NASDAQHealthcare$0.69-4.98%ClosedMarket Cap: $115.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.82
P/S
0.00
EV/EBITDA
-0.24
DCF Value
$0.57
FCF Yield
-62.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-85.2%
ROA
-61.7%
ROIC
-69.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-20.8M | $-20.2M | $-0.12 | — |
| FY 2025 | $0.00 | -Infinity% | $-93.3M | $-90.6M | $-0.59 | — |
| Q3 2025 | $0.00 | -Infinity% | $-20.9M | $-20.3M | $-0.12 | — |
| Q2 2025 | $0.00 | -Infinity% | $-24.1M | $-23.3M | $-0.14 | — |
| Q1 2025 | $0.00 | NaN% | $-27.5M | $-26.9M | $-0.24 | — |
| Q4 2024 | $0.00 | NaN% | $-24.7M | $-23.8M | $-0.28 | — |
| FY 2024 | $0.00 | -Infinity% | $-115.9M | $-111.1M | $-1.31 | — |
| Q3 2024 | $0.00 | NaN% | $-26.7M | $-25.6M | $-0.30 | — |
| Q2 2024 | $0.00 | -Infinity% | $-30.8M | $-29.4M | $-0.34 | — |
| Q1 2024 | $0.00 | -Infinity% | $-33.8M | $-32.2M | $-0.40 | — |
| Q4 2023 | $0.00 | -Infinity% | $-31.4M | $-29.9M | $-0.44 | — |
| FY 2023 | $0.00 | -Infinity% | $-131.2M | $-124.1M | $-1.68 | — |